As filed with the U.S. Securities and Exchange Commission on March 23, 2023. Registration No. 333-261945 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 16 to FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 HONGLI GROUP INC. (Exact Name of Registrant as Specified in its Charter) (State or Other Jurisdiction of Incorporation or Organization) Cayman Islands 3569 Not applicable (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Ident ...

As filed with the U.S. Securities and Exchange Commission on February 27, 2023. Registration No. 333-261945 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 15 to FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 HONGLI GROUP INC. (Exact Name of Registrant as Specified in its Charter) (State or Other Jurisdiction of Incorporation or Organization) Cayman Islands 3569 Not applicable (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Id ...

Registration No. 333-269653 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 To As filed with the Securities and Exchange Commission on February 9, 2023 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Tenon Medical, Inc. (Exact name of registrant as specified in its charter) (State or Other Jurisdiction of Incorporation or Organization) (Primary Standard Industrial Classification Code Number) Delaware 3841 45-5574718 (I.R.S. Employer Identification No. ...

As filed with the Securities and Exchange Commission on January 31, 2023 Registration No. 333-267803 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (Address, including zip code, and telephone number, including area code, of principal executive offices) Amendment No. 2 To FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 5E Advanced Materials, Inc. (Exact name of registrant as specified in its charter) Not Applicable (Translation of Registrant's Name into English) (Sta ...

As filed with the U.S. Securities and Exchange Commission on January 26, 2023 Registration No. 333-268283 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1/A (AMENDMENT NO. 2) REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 PONO CAPITAL THREE, INC. (Exact name of registrant as specified in its charter) Cayman Islands 6770 N/A (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identifi ...

Registration No. 333-268283 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 As filed with the U.S. Securities and Exchange Commission on January 26, 2023 FORM S-1/A (AMENDMENT NO. 2) REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 PONO CAPITAL THREE, INC. (Exact name of registrant as specified in its charter) Cayman Islands 6770 N/A (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identifi ...

Table of Contents As filed with the Securities and Exchange Commission on January 24, 2023 Registration No. 333-269238 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 NEXTRACKER INC. (Exact name of registrant as specified in its charter) Copies of all communications, including communications sent to agent for service, should be sent to: Heather Childress, Esq. Senior Vice President, Deputy General Cou ...

As filed with the Securities and Exchange Commission on January 20, 2023 Registration No. 333-269188 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to Form S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CHROMOCELL THERAPEUTICS CORPORATION (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Delaware 2836 86-3335449 (Primary Standard Industrial Classification Code Number) If any of the secur ...

费用与支付 - 发行和分销其他估计费用为80万美元，包括法律费用40万等[9] - 2022年1月26日发起人支付2.5万美元获575万股B类普通股[13] 股份变动 - 2022年3月4日公司对B类普通股115万股股份资本化[13] - 2022年8月18日发起人无偿交出115万股B类普通股[13] - 2022年11月17日发起人无偿交出95.8333万股，B类普通股降至479.1667万股[13][14] 私募单位 - 发起人、承销商承诺购买72.5万份私募单位，超额行使则买76.25万份[16] 公司性质 - 公司为非加速申报、较小规模报告、新兴成长公司[5] 其他事项 - 本次修订案提交表格S - 1的附件1.1等[7] - 公司预计购买董事和高级管理人员责任保险[10] - 公司董事和高级管理人员放弃对信托账户资金权利和索赔[11] - 注册声明规定确定购买者责任[23] - 注册人承担证券首次发行对购买者责任[23] - 注册声明于2023年1月11日在得克萨斯州签署[25] - Ziv Elul、Sharon Barzik Cohen以相关身份签署注册声明[25][26]

As filed with the United States Securities and Exchange Commission on January 11, 2023 No. 333-263658 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 4 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Israel Acquisitions Corp (Exact name of registrant as specified in its charter) Copies to: Will Chuchawat Proskauer Rose LLP 2029 Century Park East, Suite 2400 Los Angeles, CA 90067 Tel: (310) 284-4550 Fax: (310) 557-2193 (State or other jurisdiction of ...